FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
Skip Navigation LinksHome / News / Read News


Bank of America Leads Lenders in Cantel Medical’s $250MM Credit Facility

March 06, 2014, 07:22 AM
Filed Under: Medical

Cantel Medical has entered into an amended and restated credit facility which established new terms under its revolving credit facility with its existing bank group led by Bank of America, N.A., and including Wells Fargo Bank, N.A. and PNC Bank, N.A.

"We are pleased that we were able to expand the capacity, lengthen the maturity and establish more favorable terms under our credit facility.  This new facility provides us with increased financial flexibility and access to more capital to support the company's continued growth through 2019," said Craig Sheldon, Cantel Medical's Senior Vice President, Chief Financial Officer and Treasurer.

The amended and restated credit facility includes the following:

  • an expansion of total borrowing capacity to $250 million, up from $150 million for the prior credit facility;
  • an option to increase the aggregate size of the credit facility by $100 million with additional commitments;
  • a decrease in the applicable rates used for borrowings and a decrease in the annual commitment fee;
  • the ability to borrow funds in all major currencies; and
  • an extension of the credit facility's maturity date to March 4, 2019.

Cantel Medical plans to use the new credit facility to refinance the company's borrowings under its existing facility and for capital expenditures, acquisitions, and other general corporate purposes.

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention and control products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives.  The company's products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products, and specialty packaging for infectious and biological specimens.

Week's News

Comments From Our Members

You must be an ABL Advisor member to post comments. Login or Join Now.